ID: ALA13112

Max Phase: Preclinical

Molecular Formula: C13H17NO3

Molecular Weight: 235.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cc2c(cc1OC)CC(C)(C)[N+]([O-])=C2

Standard InChI:  InChI=1S/C13H17NO3/c1-13(2)7-9-5-11(16-3)12(17-4)6-10(9)8-14(13)15/h5-6,8H,7H2,1-4H3

Standard InChI Key:  GCRKEHSDKAOUCX-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 235.28Molecular Weight (Monoisotopic): 235.1208AlogP: 1.97#Rotatable Bonds: 2
Polar Surface Area: 44.53Molecular Species: ACIDHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.68CX Basic pKa: CX LogP: -1.07CX LogD: 0.95
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.58Np Likeness Score: 0.83

References

1. Bernotas RC, Thomas CE, Carr AA, Nieduzak TR, Adams G, Ohlweiler DF, Hay DA.  (1996)  Synthesis and radical scavenging activity of 3,3-dialkyl-3,4-dihydro-isoquinoline 2-oxides,  (10): [10.1016/0960-894X(96)00181-3]

Source